Louis H. Morrone - Dec 6, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Dec 6, 2021
Transactions value $
-$1,681,388
Form type
4
Date filed
12/8/2021, 04:25 PM
Previous filing
Jul 6, 2021
Next filing
Dec 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $483K +9.99K +26.13% $48.34 48.2K Dec 6, 2021 Direct
transaction ABT Common shares without par value Sale -$1.31M -9.99K -20.72% $131.01 38.2K Dec 6, 2021 Direct F1
transaction ABT Common shares without par value Options Exercise $483K +9.99K +26.13% $48.34 48.2K Dec 7, 2021 Direct
transaction ABT Common shares without par value Sale -$1.34M -9.99K -20.71% $134.00 38.2K Dec 7, 2021 Direct
holding ABT Common shares without par value 2.3K Dec 6, 2021 Profit Sharing Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -9.99K -33.34% $0.00 20K Dec 6, 2021 Common Shares 9.99K $48.34 Direct F3
transaction ABT Option (right to buy) Options Exercise $0 -9.99K -50% $0.00 9.99K Dec 7, 2021 Common Shares 9.99K $48.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.16, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.
F3 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).